ロード中...
Potential for subsets of wt-NPM1 primary AML blasts to respond to retinoic acid treatment
Acute myeloid leukemia (AML) has high mortality rates, perhaps reflecting a lack of understanding of the molecular diversity in various subtypes and a lack of known actionable targets. There are currently 12 open clinical trials for AML using combination therapeutic modalities including all-trans re...
保存先:
| 出版年: | Oncotarget |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Impact Journals LLC
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5790527/ https://ncbi.nlm.nih.gov/pubmed/29423110 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.23642 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|